The varicella-zoster virus (VZV) causes chickenpox or varicella, a disease primarily in children, and Herpes Zoster (HZ) or zoster or shingles, a disease that affects adults. A 2-dose Varicella vaccination is recommended in the United States, the first dose at age 15-18 months and the second dose at 4 to 6 years. In this study, we used multinomial logistic regression to analysis data from the 2011 National Immunization Survey-Teen (NIS-Teen) to identify factors that have a significant impact on the number of doses (0-dose, 1-dose, or 2-dose) a teen will have. We evaluate Varicella vaccination coverage stratified by Census region and assessed factors independently associated with varicella vaccination.